CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Seroprevalance of dengue and chikungunya co infection and its clinical correlation in bangalore city hospitals

Author: 
Dr. Karthik, R., Dr. Vineetha, K. R., Dr. Raut, C. G., Dr. Nazim Shaik and Manjunatha
Subject Area: 
Health Sciences
Abstract: 

Introduction: Arthropod-borne viruses or arboviruses are one of the major public health problems worldwide. Out of many arboviruses, chikungunya virus (CHIKV) and dengue virus (DENV) are the two most rapidly spreading arboviruses. Serological investigations in Southern India indicate that the two viruses can co-exist in the same host. Many risk factors for chikungunya virus (CHIKV) and dengue virus (DENV) infections are the same or similar. OBJECTIVES: The present study is conducted to know the seroprevalance of dengue and chikungunya co infection and its clinical correlation. Materials and Methods: The blood samples collected from patients were sent along with details of the patient, clinical findings, and investigations done from various Bangalore city hospitals from the month of January 2013 to December2013, to check for the presence of IgM antibodies in serum against Dengue or Chikungunya were subjected to an enzyme-linked immunosorbent assay (ELISA) test to detect the presence of immunoglobulin M (IgM) antibodies against both CHIKV and DENV. Results: Out of 4296 serum samples studied 205 (7.6%) samples were positive for both Dengue and Chikungunya. Majority of the cases were from the age group of 11-20 years (31.21%). A seasonal peak was seen in the months of June to August. Of the total number of affected cases, 89(43.41%) were females and 116 (56.58%) were males. Fever and was seen in almost all the cases (99 %), thrombocytopenia in 92.17%, and myalgia in 56.1% of seropositive cases. Chills, headache, arthralgia, vomiting were observed in 60.48%, 48.8 %, 40.4% and 35.6% seropositive cases respectively. Features of dengue complications like hypotension, hypoalbuminemia, rising hematocrit and hemorrhagic manifestations were seen in 7.8%, 1.4%, 2.4% and 7.3% cases respectively. Conclusion: With the urbanization that is occurring in India, the incidence of dengue infection is increasing dramatically. With the expectation that cases of co infection with DENV and CHIKV will become more prevalent in the future due to increased transmission of both viruses in various areas of India, enhanced surveillance to clinically and diagnostically differentiate CHIKV and DENV infections is needed for early recognition of virus invasion and local transmission, better patient care, and timely control measures. With clinical examination of CHIKV/DENV coinfected patients has not yet allowed the identification of specific or severe symptoms, such observations should be interpreted with caution. Our findings may add to the recognition of CHIKV/DENV coinfections and suggest that tests to detect the presence of both viruses should be carried out in individuals showing clinical signs of an infection with either CHIKV or DENV.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran